Search
for
Sort by
Research 541–570 of 651
- Case-Only Trees and Random Forests for Exploring Genotype-Specific Treatment Effects in Randomized Clinical Trials with Dichotomous End Points
- Adherence with protocol medication use and mortality from unrelated causes in a prevention trial
- Battling a receding tide: Treatment for androgenic alopecia
- Comparative genomics analyses of alpha-keratins reveal insights into evolutionary adaptation of marine mammals
- Development, Optimization, and In Vitro/In Vivo Evaluation of Azelaic Acid Transethosomal Gel for Antidermatophyte Activity
- Fully automated chip-based nanoelectrospray ionization-mass spectrometry as an effective tool for rapid and high-throughput screening of 5α-reductase inhibitors
- Genetic Polymorphisms of Immunity Regulatory Genes and Alopecia Areata Susceptibility in Jordanian Patients
- The “Bald Mill Hill” Mutation in the Mouse Is Associated with an Abnormal, Mislocalized HR bmh Protein
- Comparative Analysis of Chloroplast Genomes in Sansevieria Reveals Phylogenetic Relationships and High Variability Molecular Markers
- A systematic review on Drug Re-profiling/Re-Purposing
- PSA Test Sensitized by Finasteride
- MP31-04 HOW DO 5-ALPHA-REDUCTASE INHIBITORS CHANGE PSA DENSITY IN PATIENTS ON ACTIVE SURVEILLANCE?
- PSA concentration change in men taking low dose finasteride and dutasteride for male androgenetic alopecia
- Modelling of the composition of emulsion medicines and cosmetics stabilized by a biocomplex of surfactant substances based on rhamnolipids Pseudomonas sp. PS-17
- Atherogenesis: Estrogen Induction of Polysialylated nCAM (PSA-nCAM) Blocks Monocyte Capture by Vascular Endothelial Cells
- 1450 THE TRUE BENEFIT OF PSA-SCREENING: MODELING THE IMPACT OF TRIAL SETTING AND PROTOCOL ON MORTALITY
- 42134 Long-term Efficacy of Guselkumab (GUS) on Fatigue and Identification of Early Treatment Targets: Post Hoc Analysis Through 2 Years of a Phase 3, Randomized, Double-blind, Placebo-controlled Study in Biologic-naïve Patients With Psoriatic Arthritis (PsA)
- Dutasteride for the treatment of benign prostatic hyperplasia
- Medikamentöse Therapie des benignen Prostatasyndroms
- Dutasteride, a novel dual 5-A reductase inhibitor, reduces serum DHT to a greater extent versus finasteride and achieves finasteride maximal reduction in a larger proportion of patients
- Interaction between estrogens and androgen receptor genes microsatellites, prostate-specific antigen and androgen receptor expressions in breast cancer
- Evaluation of healthcare for transgender veterans
- Cervi Parvum Cornu complex for men with lower urinary tract symptoms: a multicenter, randomized, double-blind, placebo-controlled trial
- Finasteride in Androgenic Alopecia
- Ixekizumab improves physical function, quality of life, and work productivity in biologic disease-modifying antirheumatic drug-naive patients with active psoriatic arthritis
- Trichoscopy in alopecias
- The finasteride riddle
- Upadacitinib Efficacy for the Treatment of Concomitant Psoriasis and Alopecia Areata
- Prostate Specific Antigen in Different Dermatoses Associated with Polycystic Ovary: Review Article
- Addressing Autoimmune and Immune-mediated Skin Disease Burden in Women